Loading…
Option Care Health, Inc. is projected to rise to $23.71 by 2027, a +10% move from its current price of $21.57. OPCH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $21.19 | $21.58 | $21.98 | +0.05% |
| Jul 14 | $21.04 | $21.59 | $22.16 | +0.09% |
| Jul 15 | $20.93 | $21.60 | $22.29 | +0.14% |
| Jul 16 | $20.83 | $21.61 | $22.41 | +0.19% |
| Jul 17 | $20.75 | $21.62 | $22.52 | +0.23% |
| Jul 18 | $20.68 | $21.63 | $22.62 | +0.28% |
| Jul 19 | $20.62 | $21.64 | $22.71 | +0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.62 | $21.64 | $22.71 | +0.33% |
| Week 2 | $20.28 | $21.71 | $23.25 | +0.65% |
| Week 3 | $20.03 | $21.78 | $23.68 | +0.98% |
| Week 4 | $19.84 | $21.85 | $24.07 | +1.31% |
| Week 5 | $19.68 | $21.92 | $24.43 | +1.64% |
| Week 6 | $19.54 | $21.99 | $24.76 | +1.97% |
| Week 7 | $19.42 | $22.07 | $25.08 | +2.30% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Option Care Health, Inc. is a healthcare company that provides home and alternate-site infusion services in the United States. It offers anti-infective therapy and home infusion services to treat heart failure, along with home parenteral nutrition and enteral nutrition support for a range of acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases.
The company also delivers immunoglobulin infusion therapies for immune deficiencies and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other conditions. It provides therapies to manage neurological disorders such as Duchenne muscular dystrophy, multiple sclerosis, and Alzheimer's disease, as well as infusion therapies for bleeding disorders and high-risk pregnancies.
In addition, Option Care Health offers infusion therapies for pain management, chemotherapy, and respiratory medications, along with nursing services. The company markets its services through referrals from physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. It is headquartered in Bannockburn, Illinois.
Option Care Health, Inc. (OPCH) is currently trading with a price of $21.99. It has a market capitalization of $3.45B and a rank of 1649. The stock sits in the Healthcare sector based on its category.
The near-term outlook shows a neutral sentiment with a 30-day price range of $19.20 to $25.19, a sentiment read of NEUTRAL, and key technical levels including RSI14 at 50, SMA50 at $23.04, and SMA200 at $28.58. Support is cited at $19.52 and resistance at $22.23.
Longer-term projections imply a bullish trajectory, with average price levels and potential returns rising meaningfully through 2030 and beyond. The forecasted averages span from 2026 through 2050, with the 2030 average price of $33.23 and a 2050 average of $135.64, alongside substantial cumulative ROI growth.
A major floor 10.6% below — a decisive break under it would weaken the trend.
The nearest floor, 7.0% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 44.6% above — clearing it would confirm fresh momentum.
Key OPCH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OPCH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.53 | Buy | $21.55 | Buy |
| MA 10 | $21.47 | Buy | $21.51 | Buy |
| MA 20 | $21.48 | Buy | $21.46 | Buy |
| MA 50 | $21.10 | Buy | $22.36 | Sell |
| MA 100 | $25.44 | Sell | $24.51 | Sell |
| MA 200 | $28.08 | Sell | $26.75 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.38 | Neutral |
| Stoch RSI (14) | 62.43 | Neutral |
| CCI (20) | 20.24 | Neutral |
| Williams %R (14) | -42.31 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | -1.82 | Sell |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 57.69 | Neutral |
| TRIX (15) | -0.01 | Sell |
| Awesome (5,34) | 0.29 | Buy |
| Ultimate (7,14,28) | 57.58 | Neutral |
| Momentum (10) | 0.09 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 21.63 | Sell |
| ADX (14) | 9.07 | Neutral |
| ATR (14) | 0.37 | Info |
The near-term technical picture is neutral. RSI14 is 50, indicating balanced momentum without overbought or oversold signals. The stock remains near a middle ground between its moving averages.
SMA50 at $23.04 and SMA200 at $28.58 provide nearby relationship checkpoints, with immediate price action likely to test the $22.23 resistance and the $19.52 support. The 30-day price range runs from $19.20 to $25.19, illustrating modest near-term volatility.
Overall, the short-term setup suggests a cautious stance, with limited directional bias as market participants await catalysts.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.52 | $21.57 | $29.36 | 0% | Neutral | |
| $19.42 | $23.71 | $30.26 | +10% | Neutral | |
| $20.71 | $25.76 | $33.78 | +19% | Neutral | |
| $22.60 | $28.55 | $38.23 | +32% | Bullish | |
| $25.65 | $32.84 | $44.76 | +52% | Bullish | |
| $29.86 | $38.69 | $53.58 | +79% | Bullish | |
| $30.12 | $39.47 | $55.43 | +83% | Bullish | |
| $30.53 | $40.42 | $57.51 | +87% | Bullish | |
| $33.19 | $44.39 | $63.90 | +106% | Bullish | |
| $34.07 | $45.99 | $66.94 | +113% | Bullish | |
| $46.07 | $64.87 | $98.95 | +201% | Bullish | |
| $93.04 | $140.51 | $229.75 | +551% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.52 | $21.57 | $25.87 | +0.00% |
| August 2026 | $19.22 | $22.49 | $26.90 | +4.28% |
| September 2026 | $19.13 | $22.50 | $27.12 | +0.04% |
| October 2026 | $19.22 | $22.69 | $27.53 | +0.86% |
| November 2026 | $19.86 | $23.54 | $28.71 | +3.72% |
| December 2026 | $20.14 | $23.95 | $29.36 | +1.72% |
Click any year to see its month-by-month OPCH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect OPCH to range from $19.52 to $29.36 through 2026. The $21.57 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The OPCH price prediction for 2027 points to an average of $23.71 (low $19.42, high $30.26) — a potential gain of +10% on today's $21.57. Price action looks broadly range-bound.
In 2028, OPCH is projected to trade between $20.71 and $33.78, averaging $25.76 — a potential gain of +19% from today's $21.57. That is up +9% on the projected 2027 average. A consolidation phase looks the most probable path here.
Option Care Health, Inc.'s 2029 outlook centres on $28.55, within a $22.60 to $38.23 range. That is up +11% on the projected 2028 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2030, OPCH could reach as high as $44.76, with a base case around $32.84 and support toward $25.65 — roughly +52% from $21.57. Buyers look set to stay in control over this stretch.
Expect OPCH to range from $29.86 to $53.58 through 2031. The $38.69 average target implies a +79% move from current prices. That is up +18% on the projected 2030 average. Momentum favours further upside here.
The OPCH price prediction for 2032 points to an average of $39.47 (low $30.12, high $55.43) — a potential gain of +83% on today's $21.57. Buyers look set to stay in control over this stretch.
In 2033, OPCH is projected to trade between $30.53 and $57.51, averaging $40.42 — a potential gain of +87% from today's $21.57. That is up +2% on the projected 2032 average. Momentum favours further upside here.
Option Care Health, Inc.'s 2034 outlook centres on $44.39, within a $33.19 to $63.90 range. That is up +10% on the projected 2033 average. That marks a +106% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, OPCH could reach as high as $66.94, with a base case around $45.99 and support toward $34.07 — roughly +113% from $21.57. Momentum favours further upside here.
Expect OPCH to range from $46.07 to $98.95 through 2040. The $64.87 average target implies a +201% move from current prices. That is up +41% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The OPCH price prediction for 2050 points to an average of $140.51 (low $93.04, high $229.75) — a potential gain of +551% on today's $21.57. Momentum favours further upside here.
Investing $1,000 in OPCH today (≈ 46.360686 OPCH) could be worth
$6,514.17
+$5,514.17 (+551%) by 2050 · US Dollar
Based on the average projected OPCH price of $140.51 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OPCHwould be worth at today's price.
$1,000 invested in OPCH on Jul 10, 2025 (≈ 32.797639 OPCH) would be worth
$707.45
-$292.55 (-29.3%) today · 0.71× · US Dollar
Based on a OPCH entry price of $30.49 vs. today's $21.57.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.9 | $984.93 | -1.5% |
| 1 month ago | $21.38 | $1,008.89 | +0.9% |
| 3 months ago | $29 | $743.79 | -25.6% |
| 6 months ago | $32.06 | $672.8 | -32.7% |
| 1 year ago | $30.49 | $707.45 | -29.3% |
| All time (5.0y) ago | $21.04 | $1,025.19 | +2.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OPCH forecast.
Our base-case forecast reaches $43.00 around 2034.
Implied market cap at $43.00: $6.75B
The multi-year forecast shows a clear bullish trajectory after 2028. By 2030, the average price is projected at $33.23, with a maximum of $45.96 and a minimum of $25.66, translating to an ROI of 51.1%. The 2040 projection strengthens to an average of $64.77, a max of $101.05, a min of $45.02, with an ROI of 194.6%.
By 2050, the average is $135.64, the min $87.16, the max $227.86, and the ROI steeply higher at 516.8%. Earlier years show gradual gains as the forecast moves from 2026 through 2029 toward a bullish path.
These estimates are not guarantees and reflect projections based on available data. The near-term remains neutral, while longer-term forecasts depict a rising price trajectory with meaningful upside. Market volatility and sector-specific factors in healthcare infusion services can influence actual outcomes.
Tap a question to reveal the answer.
The forecast shows an average price of $33.23 in 2030, with a minimum of $25.66 and a maximum of $45.96. The projected ROI for 2030 is 51.1%, and the sentiment is BULLISH.
Near term is NEUTRAL, with a path toward LONG-TERM BULLISH momentum. By 2030 the average price is $33.23 and by 2050 the average reaches $135.64, with ROI figures up to 516.8%. These are estimates, not guarantees.
Yes, the forecast shows a 2034 maximum of $65.48 and a 2040 maximum of $101.05, indicating that reaching and exceeding $60 is within the projected path.
The current price is $21.99 and the market capitalization is $3.45B. The stock rank is 1649.
The 30-day range is $19.20 to $25.19.
Option Care Health, Inc. Community Discussion
0Share your Option Care Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.